Shock is a life-threatening circulatory failure that results in inadequate tissue perfusion and oxygenation. Vasopressors and inotropes are vasoactive medications that are vital in increasing systemic vascular resistance and cardiac contractility, respectively, in patients presenting with shock. To be well versed in using these agents is an important skill to have in the critical care setting where patients can frequently exhibit symptoms of shock. In this review, we will discuss the pathophysiological mechanisms of shock and evaluate the current evidence behind the management of shock with an emphasis on vasopressors and inotropes.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801. doi:https://doi.org/10.1001/jama.2016.0287
GauerRForbesDBoyerN. Sepsis: diagnosis and management. Am Fam Physician. 2020;101(7):409-418.
13.
EvansLRhodesAAlhazzaniW, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181-1247. doi:https://doi.org/10.1007/s00134-021-06506-y
14.
SerafimRGomesJASalluhJPóvoaP. A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: a systematic review and meta-analysis. Chest. 2018;153(3):646-655. doi:https://doi.org/10.1016/j.chest.2017.12.015
BalkRA. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000;16(2):179-192. doi:https://doi.org/10.1016/s0749-0704(05)70106-8
BentzerPGriesdaleDEBoydJMacLeanKSirounisDAyasNT. Will this hemodynamically unstable patient respond to a bolus of intravenous fluids?JAMA. 2016;316(12):1298-1309. doi:https://doi.org/10.1001/jama.2016.12310
19.
RhodesAEvansLEAlhazzaniW, et al.Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377. doi:https://doi.org/10.1007/s00134-017-4683-6
20.
PermpikulCTongyooSViarasilpaTTrainarongsakulTChakornTUdompanturakS. Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199(9):1097-1105. doi:https://doi.org/10.1164/rccm.201806-1034OC
21.
Ospina-TascónGAHernandezGAlvarezI, et al.Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis. Crit Care Lond Engl. 2020;24(1):52. doi:https://doi.org/10.1186/s13054-020-2756-3
Carlos SanchezEPinskyMRSinhaSMishraRCLopaAJChatterjeeR. Fluids and early vasopressors in the management of septic shock: do we have the right answers yet?J Crit Care Med Univ Med Si Farm Din Targu-Mures. 2023;9(3):138-147. doi:https://doi.org/10.2478/jccm-2023-0022
24.
GeorgeJFHamzaouiOChaariAMaizelJRichardCTeboulJL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med. 2010;36(11):1882-1889. doi:https://doi.org/10.1007/s00134-010-2013-3
25.
The National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499-510. doi:https://doi.org/10.1056/NEJMoa2212663
26.
De BackerDBistonPDevriendtJ, et al.Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789. doi:https://doi.org/10.1056/NEJMoa0907118
27.
De BackerDAldecoaCNjimiHVincentJL. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis*. Crit Care Med. 2012;40(3):725-730. doi:https://doi.org/10.1097/CCM.0b013e31823778ee
28.
AvniTLadorALevSLeiboviciLPaulMGrossmanA. Vasopressors for the treatment of septic shock: systematic review and meta-analysis. PLoS One. 2015;10(8):e0129305. doi:https://doi.org/10.1371/journal.pone.0129305
29.
JentzerJCCoonsJCLinkCBSchmidhoferM. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit. J Cardiovasc Pharmacol Ther. 2015;20(3):249-260. doi:https://doi.org/10.1177/1074248414559838
30.
JouffroyRHajjarAGilbertB, et al.Prehospital norepinephrine administration reduces 30-day mortality among septic shock patients. BMC Infect Dis. 2022;22(1):345. doi:https://doi.org/10.1186/s12879-022-07337-y
31.
SaadAFMaybauerMO. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock. J Crit Care. 2017;40:41-45. doi:https://doi.org/10.1016/j.jcrc.2017.03.008
32.
RussellJAWalleyKRSingerJ, et al.Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887. doi:https://doi.org/10.1056/NEJMoa067373
33.
JentzerJCHollenbergSM. Vasopressor and inotrope therapy in cardiac critical care. J Intensive Care Med. 2021;36(8):843-856. doi:https://doi.org/10.1177/0885066620917630
34.
PolitoAParisiniERicciZPicardoSAnnaneD. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med. 2012;38(1):9-19. doi:https://doi.org/10.1007/s00134-011-2407-x
35.
XuJCaiHZhengX. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases. BMC Infect Dis. 2023;23(1):199. doi:https://doi.org/10.1186/s12879-023-08147-6
EllenderTJSkinnerJC. The use of vasopressors and inotropes in the emergency medical treatment of shock. Emerg Med Clin North Am. 2008;26(3):759-786, ix. doi:https://doi.org/10.1016/j.emc.2008.04.001
MajureDTTeerlinkJR. Update on the management of acute decompensated heart failure. Curr Treat Options Cardiovasc Med. 2011;13(6):570-585. Published online October 6, 2011. doi:https://doi.org/10.1007/s11936-011-0149-2
42.
LöllgenHDrexlerH. Use of inotropes in the critical care setting. Crit Care Med. 1990;18(1 Pt 2):S56-S60.
43.
LevyBGibotSFranckPCravoisyABollaertPE. Relation between muscle Na + K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. Lancet Lond Engl. 2005;365(9462):871-875. doi:https://doi.org/10.1016/S0140-6736(05)71045-X
FeldmanRStantonMChinnMGraweyTWestonB. Choosing a vasopressor for a prehospital emergency medical system: consideration for agent selection and review of pharmacologic profiles, efficacy, and safety in treatment of shock. WMJ Off Publ State Med Soc Wis. 2020;119(4):240-247.
46.
OczkowskiSAlshamsiFBelley-CoteE, et al.Surviving sepsis campaign guidelines 2021: highlights for the practicing clinician. Pol Arch Intern Med. 2022;132(7-8):16290. doi:https://doi.org/10.20452/pamw.16290
47.
LewisTMerchanCAltshulerDPapadopoulosJ. Safety of the peripheral administration of vasopressor agents. J Intensive Care Med. 2019;34(1):26-33. doi:https://doi.org/10.1177/0885066616686035
48.
MedlejKKazziAAEl Hajj ChehadeA, et al.Complications from administration of vasopressors through peripheral venous catheters: an observational study. J Emerg Med. 2018;54(1):47-53. doi:https://doi.org/10.1016/j.jemermed.2017.09.007
49.
Cardenas-GarciaJSchaubKFBelchikovYGNarasimhanMKoenigSJMayoPH. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015;10(9):581-585. doi:https://doi.org/10.1002/jhm.2394
50.
HamzaouiOGouryATeboulJL. The eight unanswered and answered questions about the use of vasopressors in septic shock. J Clin Med. 2023;12(14):4589. doi:https://doi.org/10.3390/jcm12144589
51.
CharbelRCOllierVJulliandS, et al.Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children. J Am Coll Emerg Physicians Open. 2021;2(2):e12395. doi:https://doi.org/10.1002/emp2.12395
52.
WangTYParkCZhangH, et al.Management of acute traumatic spinal cord injury: a review of the literature. Front Surg. 2021;8:698736. doi:https://doi.org/10.3389/fsurg.2021.698736
53.
YueJKTsolinasREBurkeJF, et al.Vasopressor support in managing acute spinal cord injury: current knowledge. J Neurosurg Sci. 2019;63(3):308-317. doi:https://doi.org/10.23736/S0390-5616.17.04003-6
54.
AgarwalNFaramandAAlanN, et al.Lateral lumbar interbody fusion in the elderly: a 10-year experience. J Neurosurg Spine. 2018;29(5):525-529. doi:https://doi.org/10.3171/2018.3.SPINE171147
55.
GuhaATatorCHRochonJ. Spinal cord blood flow and systemic blood pressure after experimental spinal cord injury in rats. Stroke. 1989;20(3):372-377. doi:https://doi.org/10.1161/01.str.20.3.372
56.
AltafFGriesdaleDEBelangerL, et al.The differential effects of norepinephrine and dopamine on cerebrospinal fluid pressure and spinal cord perfusion pressure after acute human spinal cord injury. Spinal Cord. 2017;55(1):33-38. doi:https://doi.org/10.1038/sc.2016.79
57.
MenachoSTFloydC. Current practices and goals for mean arterial pressure and spinal cord perfusion pressure in acute traumatic spinal cord injury: defining the gaps in knowledge. J Spinal Cord Med. 2021;44(3):350-356. doi:https://doi.org/10.1080/10790268.2019.1660840
58.
SaadehYSSmithBWJosephJR, et al.The impact of blood pressure management after spinal cord injury: a systematic review of the literature. Neurosurg Focus. 2017;43(5):E20. doi:https://doi.org/10.3171/2017.8.FOCUS17428
59.
Consortium for Spinal Cord Medicine. Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals. J Spinal Cord Med. 2008;31(4):403-479. doi:https://doi.org/10.1043/1079-0268-31.4.408
60.
WaltersBCHadleyMNHurlbertRJ, et al.Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery. 2013;60(CN_suppl_1):82-91. doi:https://doi.org/10.1227/01.neu.0000430319.32247.7f
61.
GeeCMTsangABélangerLM, et al.All over the MAP: Describing pressure variability in acute spinal cord injury. Spinal Cord. 2022;60(5):470-475. doi:https://doi.org/10.1038/s41393-022-00802-0
62.
DaksonABrandmanDThibault-HalmanGChristieSD. Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study. Spinal Cord. 2017;55(11):1033-1038. doi:https://doi.org/10.1038/sc.2017.52
63.
HawrylukGWhetstoneWSaigalR, et al.Mean arterial blood pressure correlates with neurological recovery after human spinal cord injury: analysis of high frequency physiologic data. J Neurotrauma. 2015;32(24):1958-1967. doi:https://doi.org/10.1089/neu.2014.3778
64.
AgarwalNBlitsteinJLuiA, et al. Hypotension requiring vasopressor treatment and increased cardiac complications in elderly spinal cord injury patients: a prospective TRACK-SCI registry study. J Neurosurg Spine. 2023:1-9. Published online March 17, 2023. doi:https://doi.org/10.3171/2023.2.SPINE221043
65.
ReaddyWJWhetstoneWDFergusonAR, et al.Complications and outcomes of vasopressor usage in acute traumatic central cord syndrome. J Neurosurg Spine. 2015;23(5):574-580. doi:https://doi.org/10.3171/2015.2.SPINE14746
66.
InoueTManleyGTPatelNWhetstoneWD. Medical and surgical management after spinal cord injury: vasopressor usage, early surgeries, and complications. J Neurotrauma. 2014;31(3):284-291. doi:https://doi.org/10.1089/neu.2013.3061
SekarADattaDLakhaAJenaSSBansalSSahuRN. Oral midodrine as an adjunct in rapid weaning of intravenous vasopressor support in spinal cord injury. Asian J Neurosurg. 2023;18(2):306-311. doi:https://doi.org/10.1055/s-0043-1769755
69.
HongCSEffendiMKAmmarAA, et al. Use of droxidopa for blood pressure augmentation after acute spinal cord injury: case reports. Acute Crit Care. 2022. Published online December 7, 2022. doi:https://doi.org/10.4266/acc.2021.01662
SampsonHAMuñoz-FurlongACampbellRL, et al.Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397. doi:https://doi.org/10.1016/j.jaci.2005.12.1303
72.
WhitesideMFletcherA. Anaphylactic shock: no time to think. J R Coll Physicians Edinb. 2010;40(2):145-147; quiz 148. doi:https://doi.org/10.4997/JRCPE.2010.210
PumphreyRS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(8):1144-1150. doi:https://doi.org/10.1046/j.1365-2222.2000.00864.x
ThomasMCrawfordI. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J EMJ. 2005;22(4):272-273. doi:https://doi.org/10.1136/emj.2005.023507
78.
CampbellRLLiJTCNicklasRASadostyAT, Members of the Joint Task Force, Practice Parameter Workgroup. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2014;113(6):599-608. doi:https://doi.org/10.1016/j.anai.2014.10.007
79.
AvesTChopraAPatelMLinS. Epinephrine for out-of-hospital cardiac arrest: an updated systematic review and meta-analysis. Crit Care Med. 2020;48(2):225-229. doi:https://doi.org/10.1097/CCM.0000000000004130
80.
FinnJJacobsIWilliamsTAGatesSPerkinsGD. Adrenaline and vasopressin for cardiac arrest. Cochrane Database Syst Rev. 2019;2019(1):CD003179. doi:https://doi.org/10.1002/14651858.CD003179.pub2
81.
FernandoSMMathewRSadeghiradB, et al.Epinephrine in out-of-hospital cardiac arrest: a network meta-analysis and subgroup analyses of shockable and nonshockable rhythms. Chest. 2023;164(2):381-393. doi:https://doi.org/10.1016/j.chest.2023.01.033
82.
SmidaTMenegazziJJCroweRPWeissLSSalcidoDD. Association of prehospital hypotension depth and dose with survival following out-of-hospital cardiac arrest. Resuscitation. 2022;180:99-107. doi:https://doi.org/10.1016/j.resuscitation.2022.09.018
83.
WenderERCountsCRVan DykeMSayreMRMaynardCJohnsonNJ. Prehospital administration of norepinephrine and epinephrine for shock after resuscitation from cardiac arrest. Prehosp Emerg Care. 2023:1-6. Published online September 14, 2023. doi:https://doi.org/10.1080/10903127.2023.2252500
84.
BougouinWSlimaniKRenaudierM, et al.Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med. 2022;48(3):300-310. doi:https://doi.org/10.1007/s00134-021-06608-7
85.
De BackerDArias OrtizJLevyB. The medical treatment of cardiogenic shock: cardiovascular drugs. Curr Opin Crit Care. 2021;27(4):426-432. doi:https://doi.org/10.1097/MCC.0000000000000822
86.
LéopoldVGayatEPirracchioR, et al.Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018;44(6):847-856. doi:https://doi.org/10.1007/s00134-018-5222-9
87.
LevyBClere-JehlRLegrasA, et al.Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72(2):173-182. doi:https://doi.org/10.1016/j.jacc.2018.04.051
88.
RuiQJiangYChenMZhangNYangHZhouY. Dopamine versus norepinephrine in the treatment of cardiogenic shock: a PRISMA-compliant meta-analysis. Medicine (Baltimore). 2017;96(43):e8402. doi:https://doi.org/10.1097/MD.0000000000008402
89.
WhitehurstVEVickJAAllevaFRZhangJJosephXBalazsT. Reversal of propranolol blockade of adrenergic receptors and related toxicity with drugs that increase cyclic AMP. Proc Soc Exp Biol Med Soc Exp Biol Med N Y N. 1999;221(4):382-385. doi:https://doi.org/10.1046/j.1525-1373.1999.d01-96.x
90.
ColucciWSWrightRFJaskiBEFiferMABraunwaldE. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation. 1986;73(3 Pt 2):III175-III183.
91.
MathewRDi SantoPJungRG, et al.Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021;385(6):516-525. doi:https://doi.org/10.1056/NEJMoa2026845
92.
HochmanJSSleeperLAWebbJG, et al.Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341(9):625-634. doi:https://doi.org/10.1056/NEJM199908263410901
MaegeleMLeferingRYucelN, et al.Early coagulopathy in multiple injury: an analysis from the German trauma registry on 8724 patients. Injury. 2007;38(3):298-304. doi:https://doi.org/10.1016/j.injury.2006.10.003
95.
CosgriffNMooreEESauaiaAKenny-MoynihanMBurchJMGallowayB. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma. 1997;42(5):857-861; discussion 861-862. doi:https://doi.org/10.1097/00005373-199705000-00016
96.
FerraraAMacArthurJDWrightHKModlinIMMcMillenMA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg. 1990;160(5):515-518. doi:https://doi.org/10.1016/s0002-9610(05)81018-9
97.
OwensTMWatsonWCProughDSUchidaTKramerGC. Limiting initial resuscitation of uncontrolled hemorrhage reduces internal bleeding and subsequent volume requirements. J Trauma. 1995;39(2):200-207; discussion 208-209. doi:https://doi.org/10.1097/00005373-199508000-00004
98.
BickellWHWallMJPepePE, et al.Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105-1109. doi:https://doi.org/10.1056/NEJM199410273311701
99.
CottonBAJeromeRCollierBR, et al.Guidelines for prehospital fluid resuscitation in the injured patient. J Trauma. 2009;67(2):389-402. doi:https://doi.org/10.1097/TA.0b013e3181a8b26f
100.
TishermanSASchmickerRHBraselKJ, et al.Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the Resuscitation Outcomes Consortium. Ann Surg. 2015;261(3):586-590. doi:https://doi.org/10.1097/SLA.0000000000000837
ShackelfordSADel JuncoDJPowell-DunfordN, et al.Association of prehospital blood product transfusion during medical evacuation of combat casualties in Afghanistan with acute and 30-day survival. JAMA. 2017;318(16):1581-1591. doi:https://doi.org/10.1001/jama.2017.15097
103.
SperryJLGuyetteFXBrownJB, et al.Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;379(4):315-326. doi:https://doi.org/10.1056/NEJMoa1802345
104.
GuyetteFXSperryJLPeitzmanAB, et al.Prehospital blood product and crystalloid resuscitation in the severely injured patient: a secondary analysis of the prehospital air medical plasma trial. Ann Surg. 2021;273(2):358-364. doi:https://doi.org/10.1097/SLA.0000000000003324
105.
CrombieNDoughtyHABishopJRB, et al.Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2022;9(4):e250-e261. doi:https://doi.org/10.1016/S2352-3026(22)00040-0
106.
HolcombJBDel JuncoDJFoxEE, et al.The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127. doi:https://doi.org/10.1001/2013.jamasurg.387
107.
HolcombJBTilleyBCBaraniukS, et al.Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471. doi:https://doi.org/10.1001/jama.2015.12
108.
MorrisonJJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113. doi:https://doi.org/10.1001/archsurg.2011.287
109.
RobertsIShakurHCoatsT, et al.The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess Winch Engl. 2013;17(10):1-79. doi:https://doi.org/10.3310/hta17100
110.
The PATCH-Trauma Investigators and the ANZICS Clinical Trials Group. Prehospital tranexamic acid for severe trauma. N Engl J Med. 2023;389(2):127-136. doi:https://doi.org/10.1056/NEJMoa2215457
111.
HolcombJBJenkinsDH. Get ready: whole blood is back and it’s good for patients. Transfusion (Paris). 2018;58(8):1821-1823. doi:https://doi.org/10.1111/trf.14818
112.
CottonBAPodbielskiJCampE, et al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013;258(4):527-532; discussion 532-533. doi:https://doi.org/10.1097/SLA.0b013e3182a4ffa0
113.
BrillJBTangBHattonG, et al.Impact of incorporating whole blood into hemorrhagic shock resuscitation: analysis of 1,377 consecutive trauma patients receiving emergency-release uncrossmatched blood products. J Am Coll Surg. 2022;234(4):408-418. doi:https://doi.org/10.1097/XCS.0000000000000086
114.
HazeltonJPSsentongoAEOhJS, et al.Use of cold-stored whole blood is associated with improved mortality in hemostatic resuscitation of major bleeding: a multicenter study. Ann Surg. 2022;276(4):579-588. doi:https://doi.org/10.1097/SLA.0000000000005603
115.
NordinAJMäkisaloHHöckerstedtKA. Failure of dobutamine to improve liver oxygenation during resuscitation with a crystalloid solution after experimental haemorrhagic shock. Eur J Surg Acta Chir. 1996;162(12):973-979.
116.
GaussTRichardsJETortùC, et al.Association of early norepinephrine administration with 24-hour mortality among patients with blunt trauma and hemorrhagic shock. JAMA Netw Open. 2022;5(10):e2234258. doi:https://doi.org/10.1001/jamanetworkopen.2022.34258
117.
GaussTGayatEHarroisA, et al.Effect of early use of noradrenaline on in-hospital mortality in haemorrhagic shock after major trauma: a propensity-score analysis. Br J Anaesth. 2018;120(6):1237-1244. doi:https://doi.org/10.1016/j.bja.2018.02.032
118.
MoralesDMadiganJCullinaneS, et al.Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation. 1999;100(3):226-229. doi:https://doi.org/10.1161/01.cir.100.3.226
119.
CohnSMMcCarthyJStewartRMJonasRBDentDLMichalekJE. Impact of low-dose vasopressin on trauma outcome: prospective randomized study. World J Surg. 2011;35(2):430-439. doi:https://doi.org/10.1007/s00268-010-0875-8
120.
SimsCAHolenaDKimP, et al.Effect of low-dose supplementation of arginine vasopressin on need for blood product transfusions in patients with trauma and hemorrhagic shock: a randomized clinical trial. JAMA Surg. 2019;154(11):994-1003. doi:https://doi.org/10.1001/jamasurg.2019.2884
121.
CollierBDossettLMannM, et al.Vasopressin use is associated with death in acute trauma patients with shock. J Crit Care. 2010;25(1):173.e9-173.e14. doi:https://doi.org/10.1016/j.jcrc.2009.05.003
122.
PluradDSTalvingPLamLInabaKGreenDDemetriadesD. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma. 2011;71(3):565-570; discussion 570-572. doi:https://doi.org/10.1097/TA.0b013e3182213d52
123.
AokiMAbeTSaitohDHagiwaraSOshimaK. Use of vasopressor increases the risk of mortality in traumatic hemorrhagic shock: a nationwide cohort study in Japan. Crit Care Med. 2018;46(12):e1145-e1151. doi:https://doi.org/10.1097/CCM.0000000000003428
124.
FisherADAprilMDCunninghamCSchauerSG. Prehospital vasopressor use is associated with worse mortality in combat wounded. Prehosp Emerg Care. 2021;25(2):268-273. doi:https://doi.org/10.1080/10903127.2020.1737280
125.
SpahnDRBouillonBCernyV, et al.The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care Lond Engl. 2019;23(1):98. doi:https://doi.org/10.1186/s13054-019-2347-3
126.
Gitz HollerJJensenHKHenriksenDP, et al.Etiology of shock in the emergency department: a 12-year population-based cohort study. Shock Augusta Ga. 2019;51(1):60-67. doi:https://doi.org/10.1097/SHK.0000000000000816
van DiepenSKatzJNAlbertNM, et al.Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232-e268. doi:https://doi.org/10.1161/CIR.0000000000000525
133.
McDonaghTAMetraMAdamoM, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:https://doi.org/10.1093/eurheartj/ehab368
134.
KhannaAEnglishSWWangXS, et al.Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377(5):419-430. doi:https://doi.org/10.1056/NEJMoa1704154
135.
AngiotensinII. Dosing and indications. In: Columbia Basin College Library, ed. Micromedex [Electronic version]. Truven Health Analytics; 2023. Accessed December, 2023. http://www.micromedexsolutions.com/.
